Chica-Parrado, M.R.; Godoy-Ortiz, A.; Jiménez, B.; Ribelles, N.; Barragan, I.; Alba, E.
Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors. Cancers 2020, 12, 2012.
https://doi.org/10.3390/cancers12082012
AMA Style
Chica-Parrado MR, Godoy-Ortiz A, Jiménez B, Ribelles N, Barragan I, Alba E.
Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors. Cancers. 2020; 12(8):2012.
https://doi.org/10.3390/cancers12082012
Chicago/Turabian Style
Chica-Parrado, MarÃa Rosario, Ana Godoy-Ortiz, Begoña Jiménez, Nuria Ribelles, Isabel Barragan, and Emilio Alba.
2020. "Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors" Cancers 12, no. 8: 2012.
https://doi.org/10.3390/cancers12082012
APA Style
Chica-Parrado, M. R., Godoy-Ortiz, A., Jiménez, B., Ribelles, N., Barragan, I., & Alba, E.
(2020). Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors. Cancers, 12(8), 2012.
https://doi.org/10.3390/cancers12082012